KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,555 | -29.6% | 2,486 | +16.5% | 0.00% | 0.0% |
| Q2 2023 | $49,061 | -22.4% | 2,134 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $63,230 | +6.4% | 2,134 | -10.3% | 0.00% | 0.0% |
| Q4 2022 | $59,405 | +19.4% | 2,380 | +4.2% | 0.00% | +50.0% |
| Q3 2022 | $49,744 | +10.6% | 2,285 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $44,992 | -53.5% | 2,285 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $96,701 | -83.6% | 2,285 | -75.3% | 0.00% | -62.5% |
| Q4 2021 | $588,298 | +8.1% | 9,266 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $544,285 | +31.1% | 9,266 | +8.2% | 0.01% | +33.3% |
| Q2 2021 | $415,257 | +236.1% | 8,562 | +169.3% | 0.01% | +200.0% |
| Q1 2021 | $123,536 | -37.3% | 3,179 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $197,098 | – | 3,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |